Insider Transactions in Q3 2025 at Eli Lilly & CO (LLY)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 01
2025
|
Melissa Seymour EVP, Global Quality |
SELL
Payment of exercise price or tax liability
|
Direct |
426
-44.8%
|
$315,240
$740.07 P/Share
|
|
Aug 01
2025
|
Melissa Seymour EVP, Global Quality |
BUY
Exercise of conversion of derivative security
|
Direct |
952
+50.0%
|
-
|
|
Jul 24
2025
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
280,000
-0.05%
|
$225,400,000
$805.95 P/Share
|
|
Jul 21
2025
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
19
+0.12%
|
$14,478
$762.18 P/Share
|
|
Jul 21
2025
|
Gabrielle Sulzberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
6
+0.23%
|
$4,572
$762.18 P/Share
|
|
Jul 21
2025
|
Mary Lynne Hedley Director |
BUY
Grant, award, or other acquisition
|
Direct |
13
+0.65%
|
$9,906
$762.18 P/Share
|
|
Jul 21
2025
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
15
+0.03%
|
$11,430
$762.18 P/Share
|
|
Jul 21
2025
|
J Erik Fyrwald Director |
BUY
Grant, award, or other acquisition
|
Direct |
13
+0.02%
|
$9,906
$762.18 P/Share
|